ene rearrangement positive non-small cell lung cancer (NSCLC) who have been treated with Crizotinib (CRZ) in England

[featured_image]

Login is required to access this page

Version
Download 0
File Size 0.00 KB
File Count 0
Create Date May 16, 2024
Last Updated November 30, -0001

ene rearrangement positive non-small cell lung cancer (NSCLC) who have been treated with Crizotinib (CRZ) in England

Attached Files